Singapore-based Golden Gate Ventures has announced its first Japanese investment from Fund IV, leading a $1.8m Pre-Series A funding round in Tokyo-based healthtech company I.W.G Inc. The investment, supported by existing investor Antler and radiologist Dr. Toshihiko Sato, will accelerate the development of I.W.G’s AI-powered platform for medical data interoperability and support its expansion across Asia.
I.W.G Inc. addresses a significant challenge in the healthcare sector—fragmented legacy systems that hinder efficient data exchange. The company’s platform allows seamless sharing of medical information across hospitals, clinics, and insurers without the need for complex hardware or costly integrations. It supports various data formats and automatically maps information into the required format for receiving institutions, overcoming system incompatibilities and language barriers.
The Asia-Pacific region is poised to be the fastest-growing market for healthcare interoperability solutions, projected to reach $14.7b by 2034. I.W.G’s technology aims to bridge the gap in digital maturity among healthcare institutions, facilitating smoother AI adoption.
Jussi Salovaara, Co-founder and Managing Partner at Antler, highlighted the importance of I.W.G’s infrastructure layer in overcoming regional compatibility and language challenges. “It’s exciting to see the team validate their approach through real customer adoption beyond Japan and backing from global investors like Golden Gate Ventures,” he said.
Founded by Xiaoyan Zhou and Xiaoxi Guo, I.W.G Inc. has been at the forefront of medical AI since 2016. The company plans to use the new capital to enhance its AI capabilities, expand its team, and deepen integrations with healthcare providers across Asia.
